AAPL 203.88 +0.14 (+0.07%)MSFT 123.45 +0.4 (+0.33%)FB 178.27 +0.03 (+0.02%)ZNGA 5.44 +0.09 (+1.59%)NVDA 186.25 +0.19 (+0.10%)WBA 54.62 -0.33 (-0.60%)GOOG 1237.48 -0.16 (-0.01%)PIH 5.25 -0.05 (-0.94%)
AAPL 203.88 +0.14 (+0.07%)MSFT 123.45 +0.4 (+0.33%)FB 178.27 +0.03 (+0.02%)ZNGA 5.44 +0.09 (+1.59%)NVDA 186.25 +0.19 (+0.10%)WBA 54.62 -0.33 (-0.60%)GOOG 1237.48 -0.16 (-0.01%)PIH 5.25 -0.05 (-0.94%)

Balance Sheet ANTH Quote Anthera Pha

All | Income Statement | Balance Sheet | Cash Flow | Retained Earnings | PPE Schedule | Intangible and Goodwill Schedule
Year 201420152016
CashAndCashEqui 47 21 2
ShortTermInvest 0 0 0
Cash 47 21 2
AccountReceivab 0 0 0
Inventories 0 0 0
DeferredIncomeT 0 0 0
OtherCurrentAss 0 0 0
TotalCurrentAss 48 23 3
PPE 2 2 2
AccumulatedDepr -1 -2 -2
NetPPE 0 1 0
EquityAndOtherI 0 0 0
Goodwill 0 0 0
IntangibleAsset 0 0 0
OtherLTAssets 0 0 0
TotalNonCurrent 0 1 0
TotalAssets 48 23 4
ShortTermDebt 0 0 0
AccountsPayable 5 5 2
TaxesPayable 0 0 0
AccruedLiabilit 1 4 3
DeferredRevenue 0 0 0
OtherCurrentLia 2 2 0
TotalCurrentLia 8 11 5
Debt 0 0 0
DeferredTaxesLi 0 0 0
DeferredRevenue 0 0 0
OtherLTLiabilit 0 0 4
TotalNonCurrent 0 0 4
TotalLiabilitie 8 11 9
CommonStock 0 0 0
AdditionalPaidI 392 411 429
RetainedEarning -352 -408 -434
AccumulatedOthe 0 0 0
TotalStockholde 40 12 -5
TotalLiabilitie 48 23 4
Anthera Pharmaceuticals Inc. income statement is the only one that provides an overview of company sales and net income
The reasoning behind the adjustment, however, is that free cash flow is meant to measure money being spent right now, not transactions that happened in the past. This makes Anthera Pharmaceuticals Inc. FCF a useful instrument for identifying growing companies with high up-front costs, which may eat into earnings now but have the potential to pay off later.